Guoqiang Dong Selected Research

Guoqiang Dong Research Topics

Disease

33	Neoplasms (Cancer) 04/2024 - 05/2010
4	Invasive Fungal Infections 12/2018 - 07/2012
2	Inflammation (Inflammations) 01/2024 - 06/2022
2	Breast Neoplasms (Breast Cancer) 12/2023 - 10/2021
2	Leukemia 01/2022 - 07/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2020
2	Colonic Neoplasms (Colon Cancer) 04/2020 - 01/2020
2	Rheumatoid Arthritis 06/2018 - 07/2015
2	Osteosarcoma (Osteogenic Sarcoma) 09/2014 - 11/2011
2	Lung Neoplasms (Lung Cancer) 06/2014 - 07/2011
1	Atopic Dermatitis (Atopic Eczema) 01/2024
1	Hepatocellular Carcinoma (Hepatoma) 12/2023
1	Ovarian Neoplasms (Ovarian Cancer) 12/2023
1	Carcinogenesis 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021
1	Invasive Candidiasis 09/2020
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2020
1	Mycoses (Diseases, Fungus) 12/2018
1	Infections 07/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2018
1	Allergic Rhinitis 06/2018
1	Asthma (Bronchial Asthma) 06/2018
1	Melanoma (Melanoma, Malignant) 01/2016
1	Phototoxic Dermatitis (Phototoxicity) 01/2016
1	Necrosis 01/2016

Drug/Important Bio-Agent (IBA)

8	snake venom protein C activatorIBA 04/2024 - 06/2021
6	Proteolysis Targeting ChimeraIBA 04/2024 - 06/2021
6	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 06/2016
5	Histone Deacetylases (Histone Deacetylase)IBA 01/2022 - 10/2017
4	Nicotinamide PhosphoribosyltransferaseIBA 12/2023 - 02/2016
3	TransferasesIBA 10/2023 - 06/2022
3	Niacinamide (Nicotinamide)FDA LinkGeneric 10/2023 - 06/2022
3	evodiamineIBA 01/2022 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 06/2021 - 06/2014
3	Antifungal AgentsIBA 12/2018 - 07/2012
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2023 - 01/2016
2	NAD (NADH)IBA 12/2023 - 01/2023
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023 - 04/2020
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 03/2021 - 12/2017
2	Histone Deacetylase InhibitorsIBA 01/2020 - 01/2020
2	nutlin 3IBA 09/2014 - 11/2011
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 07/2011 - 05/2010
1	Fluorouracil (Carac)FDA LinkGeneric 04/2024
1	ProdrugsIBA 04/2024
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 03/2024
1	CytokinesIBA 01/2024
1	phytochlorinIBA 12/2023
1	GlypicansIBA 12/2023
1	Peptides (Polypeptides)IBA 12/2023
1	Chlorambucil (Leukeran)FDA Link 12/2023
1	N-end cysteine peptide tumor-homing peptideIBA 12/2023
1	Cyclic PeptidesIBA 12/2023
1	PROTAC B3IBA 12/2023
1	Fluorescent Dyes (Fluorescent Probes)IBA 02/2023
1	Carrier Proteins (Binding Protein)IBA 06/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 06/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2021
1	Virulence Factors (Pathogenicity Factors)IBA 09/2020
1	BoratesIBA 04/2020
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2020
1	(+)-JQ1 compoundIBA 01/2020
1	Vorinostat FDA Link 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 12/2018
1	Fluconazole (Zonal)FDA LinkGeneric 07/2018
1	Janus Kinase 2IBA 07/2018
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 07/2018
1	Syk KinaseIBA 06/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Singlet OxygenIBA 01/2016
1	Photosensitizing Agents (Photosensitizers)IBA 01/2016
1	Verteporfin (Visudyne)FDA Link 01/2016
1	Benzylidene CompoundsIBA 07/2015
1	HalogensIBA 07/2014
1	TriazolesIBA 07/2014
1	piperidineIBA 07/2014
1	Irinotecan (Camptosar)FDA LinkGeneric 10/2013
1	BromidesIBA 10/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2013
1	Topotecan (Hycamtin)FDA LinkGeneric 07/2011
1	homocamptothecinIBA 07/2011
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 07/2011

Therapy/Procedure

12	Therapeutics 12/2023 - 11/2014
5	Immunotherapy 10/2023 - 12/2017
2	Photochemotherapy (Photodynamic Therapy) 12/2023 - 01/2016
1	Intravenous Injections 12/2023
1	Precision Medicine 03/2021
1	Contraindications 01/2021
1	Drug Therapy (Chemotherapy) 07/2018